First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - PHARMSURE INTERNATIONAL LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: PHARMSURE INTERNATIONAL LIMITED, 28 THE MOORLANDS TRADING ESTATE, MOOR LANE METHERINGHAM, LINCOLN, LN4 3HX. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 March 2023. The company was incorporated on 6 February 2013.

The accounts next due date is 31 December 2024. There is 1 mortgage, which is satisfied

The above was based on public record information as at 16 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 08390481
Date Incorporated: 6 February 2013
Date Latest Accounts: 31 March 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: PHARMSURE UK LIMITED
Registered Number: 08390481
Annual Return: 6 February 2016
Registered Office: 28 THE MOORLANDS TRADING ESTATE, MOOR LANE METHERINGHAM, LINCOLN, LN4 3HX
SIC Code and Operations: 75000
SECURED CREDITORS
Number of Mortgages 1
Satisfied Mortgages 1
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

PHARMSURE INTERNATIONAL LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 26 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
04202043 PHARMSURE UK LIMITED Active
12749673 PHARM-SYS LTD Active
06257723 PHARMTA LIMITED Active
14961383 PHARMTAB LTD Active
NI038060 PHARMTEC INTERNATIONAL LIMITED Dissolved

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd